Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

SKH1 hairless mice have identifiable epidermal stem cells with specific markers.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

A new staining method helps tell growing from resting hairs to diagnose hair loss.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Injecting CD34+ cell-containing platelet-rich plasma can improve pattern hair loss more than placental extract treatment.

Severe CCCA may be biologically and clinically different from milder forms.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Normal cells stain well with fluorescent globulin, but tumor cells do not.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

Calretinin identifies the companion cell layer in human hair follicles.

Hair repigmentation can indicate malignancy and should be investigated.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Cells that move well may improve hair loss treatments by entering hair follicles.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

An 87-year-old man showed unusual signs of Hodgkin lymphoma, primarily high calcium levels, which improved after treatment and revealed the disease.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Hair follicle cells resist turning into skin cells.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.